MC
ZNTL icon

Mayo Clinic’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Mayo Clinic’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$644K Sell
175,000
-12,143
-6% -$44.1K 22.19% 2
2024
Q2 		$765K Hold
187,143
– – 25.27% 2
2024
Q1 		$2.95M Hold
187,143
– – 48% 1
2023
Q4 		$2.84M Hold
187,143
– – 17.51% 2
2023
Q3 		$3.75M Hold
187,143
– – 7.23% 2
2023
Q2 		$5.28M Sell
187,143
-110,000
-37% -$2.64M 5.42% 3
2023
Q1 		$5.11M Hold
297,143
– – 4.19% 3
2022
Q4 		$5.98M Buy
+297,143
New +$6.39M 3.17% 3
2021
Q2 		$18.8M Sell
352,459
-10,000
-3% -$536K 20.74% 2
2021
Q1 		$15.7M Hold
362,459
– – 18.11% 2
2020
Q4 		$18.8M Sell
362,459
-80,255
-18% -$3.62M 22.65% 2
2020
Q3 		$14.5M Buy
442,714
+1
+0% +$35 19.5% 2
2020
Q2 		$21.3M Buy
+442,713
New +$17M 20.34% 3

Other funds holding ZNTL

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return